Sort
82,697 grants matching “vaccine development”
Novel Methods to Inform HIV/TB Clinical Trial Development
$809,775Krishna P Reddy · Massachusetts General Hospital · R01 · FY2024 · AI
HIV-1 Env immunogens that target unmutated common ancestor antibodies (UCAs) of broadly neutralizing antibodies (bnAbs) reactive with multiple HIV-1 envelope epitopes
$809,741Barton F Haynes · Duke University · UM1 · FY2024 · AI
Unmasking the roles of viral glycoproteins in oral transmission of KSHV
$809,710Javier Gordon Ogembo · Beckman Research Institute/City Of Hope · R01 · FY2022 · CA
Optimization of Lead BKIs for Cryptosporidiosis Therapy
$809,679Wesley C Van Voorhis · University Of Washington · R01 · FY2022 · AI
HIV neutralization and mechanisms of cellular entry
$809,672Sriram Subramaniam · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Role of TGF-B signaling molecules as regulators of host immune and metabolic response to parasitic nematode infection factors
$809,656Vladimir Lazetic · George Washington University · · FY2020 · BIO
Administrative Core
$809,617Jason A Mendoza · Fred Hutchinson Cancer Center · U19 · FY2025 · MD
Development of broadly neutralizing human monoclonal antibodies against henipaviruses
$809,614Benhur Lee · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · AI
Personalized neuroblastoma vaccines
$809,608John M Maris · Children'S Hosp Of Philadelphia · U01 · FY2025 · CA
Harnessing CD4 T follicular helper 1 cells for HIV vaccine efficacy
$809,526Swaminathan Smita Iyer · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · AI
Live Attenuated Bacterial Vaccines Against Plaque
$809,524James P. Nataro · University Of Maryland Baltimore · U01 · FY2008 · AI
Efficacy of immunization with 4C-MenB in preventing experimental urethral infection with Neisseria gonorrhoeae.
$809,476Joseph A Duncan · Univ Of North Carolina Chapel Hill · U01 · FY2021 · AI
MHC Variation in Host Response to SARS-CoV2 and COVID-19 Outcomes
$809,466Jill Allison Hollenbach · University Of California, San Francisco · R01 · FY2021 · AI
Investigation of Oral HPV Infection Natural History and Biomarkers of Persistent Infection: The HIM Study
$809,440Anna R Giuliano · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2018 · CA
Monitoring System For Vector-Based Influenza Vaccine
$809,394Matthew M. Ferris · Indevr, Inc. · R44 · FY2009 · AI
Identification of Candidate Gene Polymorphisms Associated with Infectious Diseas
$809,391Cheryl Ann Winkler · Basic Sciences · Z01 · FY2007 · CA
T follicular helper (Tfh) CD4+ T cell, germinal center, and antibody response dysfunction in human recurrent tonsillitis
$809,381Shane P Crotty · La Jolla Institute For Immunology · U19 · FY2023 · AI
Role of Follicular T Helper Cells In Enhancing Humoral Immunity and Protection
$809,379Rafi Ahmed · Emory University · U19 · FY2013 · AI
A rationally-designed, live-attenuated RSV vaccine for the elderly
$809,351Steffen Mueller · Codagenix, Inc. · R44 · FY2022 · AI
HIV AND HEPATITIS IN YOUNG INJECTORS: A COMMUNITY STUDY
$809,338University Of California San Francisco · R01 · FY2000 · DA
Effects of obesity on the dynamics of Influenza transmission
$809,283Stacey L Schultz-Cherry · St. Jude Children'S Research Hospital · R01 · FY2021 · AI
PEDIATRIC AIDS CLINICAL TRIAL UNIT
$809,278Katherine F Luzuriaga · Univ Of Massachusetts Med Sch Worcester · U01 · FY2006 · AI
Core--Primate
$809,273Christopher Miller · University Of California At Davis · P01 · FY2007 · AI
ACE2-targeted PET radiotracers for investigating spatiotemporal distribution of SARS-CoV-2 organ injury and therapy response.
$809,270David M Wilson · University Of California, San Francisco · R01 · FY2022 · AI
The Impact of Aging and HIV Infection on Immunologic and Transcriptomic Signatures of Influenza Vaccine Response
$809,131Albert C Shaw · Yale University · R01 · FY2019 · AG